How VC005 Tablets Work in People With Different Kidney Function
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This early-stage trial tests how the body processes VC005 tablets in people with healthy kidneys versus those with kidney problems. The goal is to understand whether kidney function affects how the drug moves through and leaves your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–70 years old
- Weight at least 50 kg (men) or 45 kg (women), with BMI between 18–32
- Willing to use effective birth control and avoid pregnancy for 3 months after the last dose
- No allergies to VC005 or any of its ingredients
- No recent blood donations, serious infections, or active herpes zoster/simplex infections
- No history of liver disease, stomach/bowel surgery, or severe digestive problems like chronic diarrhea
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body handles a new drug (D-2570) in people with normal or reduced kidney function. It helps doctors understand if the dose needs to be adjusted for kidney problems.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.